Illinois first state to legislatively mandate Alzheimer s coverage by state health plans mcknightsseniorliving.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mcknightsseniorliving.com Daily Mail and Mail on Sunday newspapers.
Today, Eli Lilly announced positive topline results from their phase 3 TRAILBLAZER-ALZ2 clinical trial of donanemab, an anti-amyloid monoclonal antibody for the treatment of early symptomatic Alzheimer s disease.